about
Disruption of the Putative Vascular Leak Peptide Sequence in the Stabilized Ricin Vaccine Candidate RTA1-33/44-198Immunization with cholesterol-rich liposomes induces anti-cholesterol antibodies and reduces diet-induced hypercholesterolemia and plaque formationIn vitro binding of anthrax protective antigen on bacteriophage T4 capsid surface through Hoc-capsid interactions: a strategy for efficient display of large full-length proteins.Facial recognition of heroin vaccine opiates: type 1 cross-reactivities of antibodies induced by hydrolytically stable haptenic surrogates of heroin, 6-acetylmorphine, and morphineLiposomes containing monophosphoryl lipid A: a potent adjuvant system for inducing antibodies to heroin hapten analogs.HIV-1, lipid rafts, and antibodies to liposomes: implications for anti-viral-neutralizing antibodies.Characterization and optimization of heroin hapten-BSA conjugates: method development for the synthesis of reproducible hapten-based vaccines.Detection of antibodies to squalene: III. Naturally occurring antibodies to squalene in humans and mice.Antibodies to squalene in US Navy Persian Gulf War veterans with chronic multisymptom illness.Platelets and erythrocyte-bound platelets bind infectious HIV-1 in plasma of chronically infected patients.Adjuvants for vaccines to drugs of abuse and addiction.Efficacy, but not antibody titer or affinity, of a heroin hapten conjugate vaccine correlates with increasing hapten densities on tetanus toxoid, but not on CRM197 carriersSynthesis of Hapten-Protein Conjugate Vaccines with Reproducible Hapten Densities.A simple nonradioactive method for the determination of the binding affinities of antibodies induced by hapten bioconjugates for drugs of abuseLiposomes containing lipid A: an effective, safe, generic adjuvant system for synthetic vaccines.Liposomal adjuvants for human vaccines.Cytotoxic T lymphocytes to Ebola Zaire virus are induced in mice by immunization with liposomes containing lipid A.Differential immune responses to HIV-1 envelope protein induced by liposomal adjuvant formulations containing monophosphoryl lipid A with or without QS21.Induction and detection of antibodies to squalene. II. Optimization of the assay for murine antibodies.The importance of antibody isotype in HIV-1 virus capture assay and in TZM-bl neutralization.Lipid binding properties of 4E10, 2F5, and WR304 monoclonal antibodies that neutralize HIV-1.Membrane-specific antibodies induced by liposomes can simultaneously bind to HIV-1 protein, peptide, and membrane lipid epitopes.Antibodies induced by liposomal protein exhibit dual binding to protein and lipid epitopes.A Stable Heroin Analogue That Can Serve as a Vaccine Hapten to Induce Antibodies That Block the Effects of Heroin and Its Metabolites in Rodents and That Cross-React Immunologically with Related Drugs of Abuse.Murine IgG subclass antibodies to antigens incorporated in liposomes containing lipid A.Calcium modulation of monoclonal antibody binding to phosphatidylinositol phosphate.Detection of liposomal cholesterol and monophosphoryl lipid A by QS-21 saponin and Limulus polyphemus amebocyte lysate.Asymmetric distribution of gangliosides in rat renal brush-border and basolateral membranesSubcellular distribution and biosynthesis of rat liver gangliosidesFibronectin binding to gangliosides and rat liver plasma membranesComplement-dependent phagocytosis of liposomes by macrophages: suppressive effects of "stealth" lipidsInduction and detection of antibodies to squaleneOil-in-water liposomal emulsions for vaccine deliveryImmunostimulatory CpG motifs induce CTL responses to HIV type I oligomeric gp140 envelope proteinLiposome-stabilized oil-in-water emulsions as adjuvants: increased emulsion stability promotes induction of cytotoxic T lymphocytes against an HIV envelope antigenPhase I study of a Neisseria meningitidis liposomal vaccine containing purified outer membrane proteins and detoxified lipooligosaccharideInfection of human peripheral blood mononuclear cells by erythrocyte-bound HIV-1: effects of antibodies and complementAn anti-phosphoinositide-specific monoclonal antibody that neutralizes HIV-1 infection of human monocyte-derived macrophages
P50
Q27676062-6FEFAF81-C3AA-4825-9CA4-66C18BC478B1Q28275313-62C8A53B-2005-4577-A822-A51915F64E5FQ33228128-AB88C8CA-4A02-4FA0-8651-66F7DB4E2B6EQ33874955-8A0D9F30-D45F-484B-9EBA-F39CE8D1E6CDQ33994987-0F48F460-73DC-4C93-AFF3-F234B840577CQ34001144-A5CD6082-765C-4369-A439-51D3A371EB70Q34144813-DD723015-0C5B-4769-B187-751267D74194Q34313931-1E155BAC-3187-49F1-931C-155C602901BEQ34976808-89B59C3F-6B3C-40B6-884A-AE4442E7E76AQ35055187-041087F5-860B-433B-8500-2AFB791EB3CDQ35493923-8B7CA2CF-F179-4DEE-B099-22EF6B090DB1Q35756201-DAB0D7B0-25EF-49F6-925A-1700E9E91E62Q35989208-DDF2CBE8-1EA0-44E1-BB78-53C82107FB59Q36480112-3EC9661A-142D-444A-A4EC-4AD85694248DQ38032881-E033686E-94F1-48EB-B351-D3A7F0DAF113Q38729260-A2ADF040-39C8-4484-B31B-A3E81F9AEB73Q40633916-59FDDE93-E232-4E49-89E3-2CA80BCFCE2EQ40998278-06BF59A8-C96E-4DB8-AEC4-D38BA6DE1DFAQ44092238-76C87D46-FFEB-41FF-98B3-88FA588096B6Q45370692-3135EBDB-4916-4B6E-8FE3-6C66FB6BF97AQ46187633-28CBC28C-5373-40B1-8D2F-68891929B869Q46441250-A9D7BE09-B326-431D-A057-35CE0CCAAA99Q46844053-DF172D48-DEA1-45B2-8AED-04827F5BF790Q47253367-312F24E8-DDE7-4ABE-B96C-8A11794BA8F7Q48024857-F1107DA7-B33A-4565-9409-DFD68DBA665EQ51582082-A4FFF5B6-79F1-4C8D-AF38-65C51D6845B5Q53667782-1BDE162C-4BAD-4325-A986-84023060D44EQ68266047-1E2695DF-7BF5-4693-9292-8BB2A01B9089Q69417551-70709D5D-49F6-45CD-A34E-67FB3FD9CEE2Q69995328-2235DBE2-0DEB-4F48-BC6E-BE033A861E3FQ70146013-8A5ED53F-9CD4-4077-8FB4-CD860283EDF4Q73103561-0235D2D5-3EA4-4FC3-ACD1-FA389C789909Q75234093-331E149E-2C9B-458B-BDAB-DF3BB0CD1FBDQ80850760-910EC639-CDF4-47DE-9285-42B02B326D53Q80850765-74D4147C-C29E-4A96-AF31-E523627C9FCAQ82790203-1099F08C-52C8-4038-A998-80688BA9A0A9Q83445829-D3E1D6A9-9EE4-4758-A972-DFB637A85750Q84222523-4AAD60E6-9150-4DE0-AAA4-D41BC8D783E2
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Gary R Matyas
@ast
Gary R Matyas
@en
Gary R Matyas
@es
Gary R Matyas
@nl
Gary R Matyas
@sl
type
label
Gary R Matyas
@ast
Gary R Matyas
@en
Gary R Matyas
@es
Gary R Matyas
@nl
Gary R Matyas
@sl
prefLabel
Gary R Matyas
@ast
Gary R Matyas
@en
Gary R Matyas
@es
Gary R Matyas
@nl
Gary R Matyas
@sl
P106
P21
P31
P496
0000-0002-2074-2373